Works matching IS 03331024 AND DT 2021 AND VI 41 AND IP 10
Results: 9
Photophobia and allodynia in persistent post-traumatic headache are associated with higher disease burden.
- Published in:
- Cephalalgia, 2021, v. 41, n. 10, p. 1089, doi. 10.1177/03331024211010304
- By:
- Publication type:
- Article
Measuring health-related quality of life in chronic headache: A comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6).
- Published in:
- Cephalalgia, 2021, v. 41, n. 10, p. 1100, doi. 10.1177/03331024211006045
- By:
- Publication type:
- Article
Clinical, oculographic, and vestibular test characteristics of vestibular migraine.
- Published in:
- Cephalalgia, 2021, v. 41, n. 10, p. 1039, doi. 10.1177/03331024211006042
- By:
- Publication type:
- Article
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Paroxysmal localized Hyperhidrosis, a case-report: When excessive sweating occurs in combination with severe headaches.
- Published in:
- Cephalalgia, 2021, v. 41, n. 10, p. 1124, doi. 10.1177/03331024211006843
- By:
- Publication type:
- Article
Letter to the editor regarding "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach.
- Published in:
- Cephalalgia, 2021, v. 41, n. 10, p. 1065, doi. 10.1177/03331024211007789
- By:
- Publication type:
- Article
Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.
- Published in:
- Cephalalgia, 2021, v. 41, n. 10, p. 1053, doi. 10.1177/03331024211006903
- By:
- Publication type:
- Article